Provided by Tiger Trade Technology Pte. Ltd.

TherapeuticsMD

2.01
+0.01000.50%
Post-market: 2.010.00000.00%16:44 EDT
Volume:22.44K
Turnover:45.13K
Market Cap:23.26M
PE:129.97
High:2.04
Open:2.01
Low:1.99
Close:2.00
52wk High:2.95
52wk Low:0.9811
Shares:11.57M
Float Shares:9.56M
Volume Ratio:0.66
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0155
EPS(LYR):-0.0527
ROE:0.32%
ROA:-2.95%
PB:0.86
PE(LYR):-38.11

Loading ...

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 23

TherapeuticsMD Inc. Stock Slides 14.1%, Underperforms Market

Dow Jones
·
Jun 19

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 16

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 12

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jun 11

TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market

Dow Jones
·
Jun 09

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 05

TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jun 03

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 30

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 22

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 21

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 19

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 14

TherapeuticsMD Q1 EPS $0.01 Up From $(0.06) YoY, Sales $724.000K Up From $393.000K YoY

Benzinga
·
May 13

TherapeuticsMD reports Q1 EPS 1c vs. (6c) last year

TIPRANKS
·
May 13

TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives

TIPRANKS
·
May 13

TherapeuticsMD swings to FY26 Q1 profit of $103,000; revenue rises 84.2% to $724,000

Reuters
·
May 13

TherapeuticsMD Inc - Company Continues to Evaluate Strategic Alternatives Including Acquisition or Merger

THOMSON REUTERS
·
May 13

Press Release: TherapeuticsMD Announces First Quarter 2026 Financial Results

Dow Jones
·
May 13

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
May 12